Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson

02-6-2024 Press Release

Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable for Anti-Competitive Tactics That Keep Drug Prices High For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – On Tuesday, February 6 at 10:00 AM, Campaign for Sustainable Rx Pricing (CSRxP) executive director Lauren Aronson will participate in a panel discussion with U.S. Senators […]

CSRXP: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 775 AS PHARMACEUTICAL INDUSTRY DOUBLES DOWN ON BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING

01-18-2024 Press Release

Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024 Continue to Outpace the Rate of Inflation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on a new report that found Big Pharma hiked prices on 775 brand name prescription […]

CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES

01-5-2024 Press Release

Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Maintain Monopoly Pricing Power and End-Run Solutions Meant to Discourage Price Increases Above the Rate of Inflation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on GSK’s strategy to discontinue the […]

CSRXP: BIG PHARMA RINGS IN 2024 WITH EGREGIOUS PRICE HIKES ON HUNDREDS OF BRAND NAME PRESCRIPTION DRUGS

01-2-2024 Press Release

Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Start the New Year For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on reports that brand name drug companies plan to hike prices on at least 500 prescription drugs to start the year, […]

CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION

12-14-2023 Press Release

Administration Announces Drug Makers Increased Prices Faster Than Rate of Inflation on 48 Medicare Part B Drugs in Final Quarter of 2023 For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday after the Biden-Harris Administration announced that Big Pharma companies increased prices faster than […]

CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL

09-14-2023 Press Release

Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer Investments Fueling Revenue for the Brand Name Drug Companies For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to brand name drug makers officially setting the list price of their COVID […]

CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients

08-24-2023 Press Release

Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity Medications More Than Five Times Higher Than Prices for Other Countries For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. –  The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday reacting to a new analysis from the Peterson-KFF Health System Tracker analyzing the […]

CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable

08-16-2023 Press Release

Americans from Across the Political Spectrum Want Congress to Pass Bipartisan Legislation to Crack Down on Big Pharma’s Abuse of the Patent System and Boost List Price Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey today. The bipartisan […]

CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION

08-9-2023 Press Release

Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for “Secondary” Patents Compared to Original Patents for New Drugs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. –  The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday reacting to a new analysis published in The Journal of American Medical Association (JAMA) examining […]

CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE

07-18-2023 Press Release

Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to Price-Gouging Patients For Immediate ReleaseContact: Jon [email protected] Washington, D.C. –  The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new round of price hikes from Big Pharma to start the month of July, as part of traditional biannual increases from the pharmaceutical […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.